Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Browne, R. Judson, W. Casey, N. Kleinstreuer, Russell Thomas (2015)
Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.Environmental science & technology, 49 14
D. Villeneuve, D. Crump, N. Garcia-Reyero, M. Hecker, T. Hutchinson, C. LaLone, B. Landesmann, T. Lettieri, S. Munn, M. Nepelska, M. Ottinger, L. Vergauwen, M. Whelan (2014)
Adverse outcome pathway development II: best practices.Toxicological sciences : an official journal of the Society of Toxicology, 142 2
K. Friedman, Eric Watt, M. Hornung, J. Hedge, R. Judson, K. Crofton, K. Houck, S. Simmons (2016)
Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.Toxicological sciences : an official journal of the Society of Toxicology, 151 1
J. Madden, V. Rogiers, M. Vinken (2014)
Application of in silico and in vitro methods in the development of adverse outcome pathway constructs in wildlifePhilosophical Transactions of the Royal Society B: Biological Sciences, 369
K. Tollefsen, S. Scholz, M. Cronin, Stephen Edwards, J. Knecht, K. Crofton, N. Garcia-Reyero, T. Hartung, Andrew Worth, G. Patlewicz (2014)
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).Regulatory toxicology and pharmacology : RTP, 70 3
G. Ankley, R. Bennett, R. Erickson, Dale Hoff, M. Hornung, Rodney Johnson, D. Mount, J. Nichols, C. Russom, P. Schmieder, Jose Serrrano, J. Tietge, D. Villeneuve (2010)
Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessmentEnvironmental Toxicology and Chemistry, 29
G. Patlewicz, Ted Simon, J. Rowlands, R. Budinsky, Richard Becker (2015)
Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.Regulatory toxicology and pharmacology : RTP, 71 3
R. Becker, G. Ankley, Stephen Edwards, S. Kennedy, I. Linkov, B. Meek, M. Sachana, H. Segner, B. Burg, D. Villeneuve, Haruna Watanabe, T. Barton-Maclaren (2015)
Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.Regulatory toxicology and pharmacology : RTP, 72 3
N. Burden, F. Sewell, M. Andersen, A. Boobis, J. Chipman, M. Cronin, T. Hutchinson, I. Kimber, M. Whelan (2015)
Adverse Outcome Pathways can drive non-animal approaches for safety assessmentJournal of Applied Toxicology, 35
M. Vinken (2013)
The adverse outcome pathway concept: a pragmatic tool in toxicology.Toxicology, 312
D. Villeneuve, D. Crump, N. Garcia-Reyero, M. Hecker, T. Hutchinson, C. LaLone, B. Landesmann, T. Lettieri, S. Munn, M. Nepelska, M. Ottinger, L. Vergauwen, M. Whelan (2014)
Adverse outcome pathway (AOP) development I: strategies and principles.Toxicological sciences : an official journal of the Society of Toxicology, 142 2
Ksenia Groh, R. Carvalho, J. Chipman, N. Denslow, M. Halder, Cheryl Murphy, D. Roelofs, A. Rolaki, K. Schirmer, Karen Watanabe (2015)
Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.Chemosphere, 120
D. Knapen, L. Vergauwen, D. Villeneuve, G. Ankley (2015)
The potential of AOP networks for reproductive and developmental toxicity assay development.Reproductive toxicology, 56
R. Judson, F. Magpantay, V. Chickarmane, C. Haskell, N. Tania, J. Taylor, M. Xia, Ruili Huang, Daniel Rotroff, D. Filer, K. Houck, Matt Martin, Nisha Sipes, A. Richard, K. Mansouri, R. Setzer, T. Knudsen, K. Crofton, Russell Thomas (2015)
Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.Toxicological sciences : an official journal of the Society of Toxicology, 148 1
V. Kramer, M. Etterson, M. Hecker, Cheryl Murphy, G. Roesijadi, Daniel Spade, J. Spromberg, Magnus Wang, G. Ankley (2011)
Adverse outcome pathways and ecological risk assessment: Bridging to population‐level effectsEnvironmental Toxicology and Chemistry, 30
J. Bailey (2003)
Food Quality Protection Act of 1996
Pierre Lacotte, D. Buisson, Y. Ambroise (2013)
Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors.European journal of medicinal chemistry, 62
N. Kleinstreuer, P. Ceger, D. Allen, J. Strickland, X. Chang, J. Hamm, W. Casey (2015)
A Curated Database of Rodent Uterotrophic BioactivityEnvironmental Health Perspectives, 124
Timothy Allen, J. Goodman, S. Gutsell, P. Russell (2014)
Defining molecular initiating events in the adverse outcome pathway framework for risk assessment.Chemical research in toxicology, 27 12
C. Mackay, Michael Davies, V. Summerfield, G. Maxwell (2013)
From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment.ALTEX, 30 4
[The Endocrine Disruptor Screening Program (EDSP) screens and tests environmental chemicals for potential effects in the estrogen, androgen, and thyroid hormone pathways, and is one of the only regulatory programs designed around a mode of action framework. A variety of biological systems affect apical endpoints used in regulatory risk assessments and without mechanistic data, endocrine disruption cannot be determined. When the EDSP was developed in 1998, computational and high throughput approaches were intended to be part of the screening process, however, methods at that time were limited in availability and performance. Recently, the revolution in automated in vitro testing and computational toxicology has generated excellent tools that can be used for endocrine screening. Toxicity pathway and Adverse Outcome Pathway frameworks facilitate integrating diverse data for screening chemicals for potential endocrine activity. In addition, pathway frameworks can be used to evaluate performance of computational approaches as alternatives for low throughput and animal-based assays. Similarly, pathway frameworks may be used to evaluate the predictive performance of one or more computational models to predict downstream key events. Computational approaches such as these may provide an alternative to the EDSP Tier 1 battery and used for weight of evidence screening of a chemical’s potential endocrine activity.]
Published: Feb 25, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.